HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William Feuer Selected Research

beta Subunit Luteinizing Hormone

2/2012Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.
1/2011Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors.
12/2010Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma.
6/2010Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate.
5/2010Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.
3/2009Blood vessel maturation in retinoblastoma tumors: spatial distribution of neovessels and mature vessels and its impact on ocular treatment.
12/2007Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
8/2007Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma.
6/2007Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse model.
4/2006Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William Feuer Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 07/2003
18Retinoblastoma (Glioblastoma, Retinal)
02/2012 - 03/2002
10Retinal Neoplasms
02/2012 - 04/2006
9Macular Degeneration (Age-Related Maculopathy)
01/2021 - 07/2009
8Dry Eye Syndromes (Dry Eye Syndrome)
01/2021 - 09/2011
5Geographic Atrophy
01/2022 - 09/2013
5Glaucoma
01/2021 - 10/2002
4Pain (Aches)
01/2021 - 01/2017
4Cataract (Cataracts)
09/2013 - 08/2004
2Polypoidal Choroidal Vasculopathy
12/2021 - 01/2020
2Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021 - 08/2004
2Atrophy
01/2020 - 01/2007
2Eye Pain
09/2019 - 01/2019
2Melanoma (Melanoma, Malignant)
01/2013 - 01/2012
2Hypoxia (Hypoxemia)
02/2012 - 12/2010
2Retinal Vein Occlusion
07/2009 - 10/2008
2Macular Edema
07/2009 - 10/2008
2Retinal Detachment (Retinal Detachments)
10/2006 - 02/2003
2Retinal Perforations
07/2006 - 02/2003
2Wounds and Injuries (Trauma)
02/2004 - 02/2003
1Disease Progression
01/2021
1Immune System Diseases (Immune Disorders)
01/2021
1Neuralgia (Stump Neuralgia)
09/2019
1Panuveitis
01/2019
1Uveitis
01/2019
1Prolapse
02/2018
1Epiretinal Membrane (Epiretinal Membranes)
01/2018
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2018
1Inflammation (Inflammations)
08/2017
1Telangiectasis (Telangiectasia)
02/2015
1Choroidal Neovascularization
09/2013
1Uveal melanoma
01/2012
1Astigmatism
02/2011
1Fuchs' Endothelial Dystrophy
06/2010
1Optic Neuritis (Retrobulbar Neuritis)
01/2010
1Keratitis
07/2009
1Neoplasm Metastasis (Metastasis)
03/2009
1Endophthalmitis (Ophthalmia)
02/2009

Drug/Important Bio-Agent (IBA)

10beta Subunit Luteinizing HormoneIBA
02/2012 - 04/2006
6Bevacizumab (Avastin)FDA Link
11/2014 - 10/2008
5Retinaldehyde (Retinal)IBA
01/2021 - 02/2003
5Carboplatin (JM8)FDA LinkGeneric
12/2010 - 02/2004
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2021
3Ranibizumab (Lucentis)FDA Link
11/2014 - 07/2009
3anecortave acetateIBA
01/2011 - 04/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 01/2021
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2020 - 07/2006
2Retinal Pigments (Pigments, Visual)IBA
01/2020 - 09/2013
2Complement System Proteins (Complement)IBA
03/2014 - 01/2014
2Eosine Yellowish-(YS) (Eosin)IBA
02/2012 - 01/2009
2Hematoxylin (Haematoxylon)IBA
02/2012 - 01/2009
2Deoxyglucose (2 Deoxy D glucose)IBA
01/2011 - 12/2010
2Angiogenesis InhibitorsIBA
06/2010 - 04/2006
1Fluorescein (Funduscein)FDA LinkGeneric
01/2021
1Pregabalin (Lyrica)FDA Link
09/2019
1Fluocinolone Acetonide (Capex)FDA LinkGeneric
01/2019
1Indicators and Reagents (Reagents)IBA
01/2019
1Ophthalmic Solutions (Eye Drops)IBA
01/2019
1Anesthetics (Anesthetic Agents)IBA
01/2019
1SteroidsIBA
01/2019
1Capsules (Microcapsules)IBA
02/2018
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2017
1proxymetacaine (Alcaine)FDA LinkGeneric
01/2017
1chemotactic factor inactivatorIBA
07/2015
1Complement Factor I (C3b Inactivator)IBA
07/2015
1afliberceptIBA
11/2014
1AndrogensIBA
07/2014
1Vitamin DFDA LinkGeneric
05/2014
1eculizumabFDA Link
03/2014
17,14-dihydroxypregn-4-ene-3,20-dioneIBA
09/2013
1Antidepressive Agents (Antidepressants)IBA
06/2012
1Histamine Antagonists (Antihistamines)IBA
06/2012
1Iodine-125IBA
01/2012
1pimonidazoleIBA
12/2010
1Matrix Metalloproteinases (MMPs)IBA
06/2010
1GelatinasesIBA
06/2010
1Green Fluorescent ProteinsIBA
05/2010
1MethylprednisoloneFDA LinkGeneric
01/2010
1Prednisone (Sone)FDA LinkGeneric
01/2010
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
02/2009

Therapy/Procedure

18Therapeutics
01/2022 - 07/2003
9Drug Therapy (Chemotherapy)
02/2012 - 07/2003
7Injections
01/2021 - 01/2005
6Radiotherapy
01/2012 - 03/2002
4Vitrectomy
01/2015 - 02/2003
3Aftercare (After-Treatment)
12/2021 - 12/2007
3Lasers (Laser)
09/2019 - 01/2007
2Intravitreal Injections
01/2021 - 01/2021
2Laser In Situ Keratomileusis (LASIK)
01/2021 - 09/2019
2Brachytherapy
01/2013 - 01/2012
2Phacoemulsification
01/2013 - 02/2003
2Corneal Transplantation (Keratoplasty)
02/2011 - 06/2010
2Contact Lenses
07/2009 - 12/2002
2Scleral Buckling
10/2006 - 03/2006
2Glaucoma Drainage Implants
12/2004 - 10/2002
2Cataract Extraction
08/2004 - 02/2003
1Operative Surgical Procedures
09/2019
1Electrodes (Electrode)
01/2018
1Cryotherapy (Therapy, Cold)
10/2012
1Complementary Therapies (Alternative Medicine)
01/2011